ArticleFrontiers in genetics2022

Predicting Differences in Treatment Response and Survival Time of Lung Adenocarcinoma Patients Based on a Prognostic Risk Model of Glycolysis-Related Genes.

Rongchang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.